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Oxidative stressThe sustained opening of the mitochondrial permeability transition pore (PTP) is a decisive event in the onset
of irreversible cell injury. The PTP is modulated by numerous exogenous and endogenous effectors, including
mitochondrial membrane potential, ions and metabolites. Mitochondrial sirtuins have recently emerged as
pivotal mediators of mitochondrial metabolism. In the present study, we demonstrate that sirt-4 modulates
sensitivity to PTP onset induced by calcium and the oxidative cross linking reagent phenylarsine oxide, and
PTP dependent cytotoxicity brought about by TNF or doxorubicin. Moreover, the ability of sirt-4 to modulate
onset of the PTP is dependent on the expression of glutamate dehydrogenase-1.
© 2012 Elsevier B.V. All rights reserved.
TECA1. IntroductionOpening of themitochondrial permeability transition pore (PTP) is a
critical juncture in the evolution of mitochondrial injury and onset of
necrotic cell death incited by a number of conditions, one prominently
being oxidative stress caused by ischemia/reperfusion [1–3]. Despite
signiﬁcant efforts, the constituents of the PTP remain remarkably elu-
sive. However, progress has been made in identifying endogenous reg-
ulators of PTP sensitivity, the most critical being cyclophilin-D [4,5].
Exogenous factors such as oxidative stress and calcium overload were
identiﬁed early on as being capable of increasing sensitivity to PTP
opening [6–8]. In particular, the thiol reactive agent, phenylarsine
oxide (PAO), served as a useful tool to study the effects of oxidative
modiﬁcation of mitochondrial constituents on PTP sensitivity [9,10]. In-
duction of PTP opening by PAO is dependent on cyclophilin-D and is
sensitive to inhibition of cyclophilin-D peptidyl-prolyl cis-trans isomer-
ase activity by agents such as cyclosporin A.
Recently, mitochondrial sirtuins have emerged as critical regulators
of mitochondrial metabolism, controlling metabolic processes such as
mitochondrial fatty acid oxidation and urea synthesis [11,12]. We have
shown that sirtuin-3 mediates the deacetylation of cyclophilin-D, and
in so doing inhibits its peptidyl-prolyl cis-trans isomerase activity [13].
Inhibition or down-regulation of sirtuin-3 increases cyclophilin-D acety-
lation and activity, which in turn sensitizesmitochondria to PTP opening.
Sirtuin-4, also localized to the mitochondria, lacks deacetylase activity,
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l rights reserved.but possesses ADP-ribosyltransferase activity [14,15]. In the present
report, we show that in contrast to sirt-3, down-regulation of sirtuin-4
expression renders mitochondria resistant to PTP induction. Moreover,
the resistance to PTP induction exerted by suppression of sirt-4 is depen-
dent on glutamate dehydrogenase-1 (GDH-1). GDH-1 is localized to the
mitochondrial matrix and is negatively regulated by sirt-4. Depletion of
GDH-1 negates the protection against PTP induction afforded by sirt-4
down-regulation, while stimulation of GDH-1 by leucine prevents PTP
induction. Moreover, suppression of sirt-4 expression protects against
PTP dependent cytotoxicity induced by TNF and doxorubicin.
2. Materials and methods
2.1. Cell culture and treatment
HeLa cells (American Type Culture Collection) were maintained in
25 cm2 ﬂasks (Corning Costar, Corning, NY) with 5 ml Dulbecco's
modiﬁed Eagle's medium containing 100 U/ml penicillin, 0.1 mg/ml
streptomycin and 10% heat-inactivated fetal bovine serum and incu-
bated at 37 °C under an atmosphere of 95% air and 5% CO2.
For time lapse ﬂuorescent microscopy, cells were plated in Labtek®
8 well chamber slides™ (Nunc, Rochester, NY) at 25,000 cells/well in
DMEM containing glucose at 4.5 g/l. Treatments with cyclosporin A
(10 μM) or leucine (1 mM) were done for 5 minutes before start of
image acquisition.
2.2. Reagents
TransIT-TKO® transfection reagent was purchased from
Mirus (Madison, WI). Phenylarsine oxide and carbonyl cyanide
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Biomol Research Laboratories. Digitonin was from Calbiochem.
Tetramethylrhodamine Methyl Ester Perchlorate (TMRM) was from
Molecular Probes (Life technologies).
2.3. siRNA mediated knockdown of sirtuin-4, sirtuin-3, sirtuin-5,
cyclophilin-D and GDH-1
A lipid based method (Mirus, Madison, WI) was used to deliver
siRNAs targeting sirtuin-4, glutamate dehydrogenase-1 (GDH-1),
sirt-3, sirt-5, cyclophilin-D (CyP-D) or a non-targeting control into
HeLa cells. The ﬁnal concentration of the siRNAs was 50 nM. The
siRNA–liposome complexes were added to the cells for 24 hours,
after which the cells were washed two times with phosphate buffered
saline and fresh complete DMEMwas added. The cells were incubated
for another 24 hours and then utilized for experiments.
2.4. Time lapse ﬂuorescence microscopy
Prior to image acquisition,HeLa cellswere loadedwith 200 nMTMRM
or 200 nMofMitoSOX for 30 minutes. Cells were thenwashed two times
withwash buffer (50 mMTris, 1 mMEGTA, pH 7.5). After a secondwash,
cells were placed in respiratory medium (0.5 mM EGTA, 3 mM MgCl2,
60 mM potassium lactobionate, 20 mM taurine, 10 mM KH2PO4,
20 mM HEPES, 110 mM sucrose, 1 g/l BSA, 2 μM oligomycin and 1 mM
of succinate as the respiratory substrate) on a heated stage maintained
at 37 °C. After initial loading, 20 nM of TMRM or 20 nM of MitoSOX
were also present in the respiratory medium to prevent their redistribu-
tion. Digitonin at 2.5 μg/ml was added to selectively permeabilize the
plasma membrane. After a ﬁve minute pre-incubation, images were
taken at 1 minute intervals for 20 minuteswith an Olympus IX 51micro-
scope at 20Xmagniﬁcation.Where indicated, phenylarsine oxide or calci-
umwere added after 2 minutes and CCCPwas added after 18 minutes to
induce complete depolarization. For determination of ROS production
with MitoSOX, the experiments were conducted as with TMRM. HeLa
cells were loaded with 5 μM of MitoSOX for 30 minutes. Treatment and
image acquisition were identical to TMRM.
Images were analyzed using Slidebook (Intelligent Imaging Inno-
vations, Denver, CO) software. Region of interests were drawn around
the cells, pixel intensity was measured and averaged for each image.
The dynamics of TMRM ﬂuorescence was calculated by the following
formula (Observed Intensity−Final Image Intensity)/(First Image
Intensity−Final Image Intensity)*100. The data were then imported
into Sigma Plot and utilized to generate line graphs for each condi-
tion. To provide more clarity to the graphs, a constant was added or
subtracted from the data sets of each condition to prevent the traces
from overlapping. Themean of the data obtained from three separate
experiments was then used to generate the line graphs presented in
Figs. 1, 2, 4 and 5. For MitoSOX, intensity measurements were done
similarly to TMRM experiments. Increases in ﬂuorescence intensity
at one minute intervals were compared to the intensity of the ﬁrst
image at the zero minute time point and represented in % by using
the formula: % change in MitoSOX ﬂuorescence intensity=(observed
image intensity−ﬁrst image intensity)/(ﬁrst image intensity)*100. A
bar graph was made using the time points at 3 and 20 minutes. The re-
sults presented are the mean of three independent experiments with
error bars indicating standard deviation.
2.5. Measurement of cell viability
Following treatments, L929 or HeLa cells were harvested and
centrifuged at 700g. The cell pelletwas re-suspended in phosphate buff-
ered saline to which was added 5 μM of propidium iodide. After
5 minutes incubation, the cells were pelleted and re-suspended
in PBS. The percentage of viable cells was determined utilizing a
Cellometer (Nexelom) as the ratio of the number of cells in the
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2.6. Micoplate assay formitochondrial depolarization and H2O2 production
HeLa cells were plated at 50,000 cells/well in 24 well plates and
transfected with the indicated siRNAs. After 48 hours, the cells were
loaded with 200 nM TMRM in DMEM for 30 minutes. After loading,
the cells were washed once with wash buffer. After washing, cells
were incubated further for 5 minutes in respiratory buffer containing
2.5 μg/ml digitonin and 20 nM of TMRM. Fluorescence intensity was
measured using a Synergy HT microplate reader with an excitation
of 550 nm and emission at 573 nm at 37 °C for 30 second intervals.
After 4 minutes, either phenylarsine oxide or Ca2+was added at the in-
dicated concentration, with ﬂuorescence measured over 20 minutes.
For complete depolarization 2.5 μMof CCCPwas added after 4 minutes.
The results are presented as % of TMRM retained in non-treated cells
transfected with non target siRNA at the 20 minute time point. For
the Amplex red assay, HeLa cells were plated and then transfected
with siRNAs targeting sirt-4, and CyP-D either individually or in tandem
with siRNA targeting GDH-1. Following 48 hours, the cells were placed
in respiratory buffer and permeabilized with digitonin (2.5 μg/ml).
Amplex-red reagentwas added at 5 μMalongwith 10 U/ml of horserad-
ish peroxidase. Following addition of Ca2+ or PAO, ﬂuorescence intensi-
ty wasmeasured using Synergy HTmicroplate reader with an excitation
of 570 nm and emission at 585 nm at 37 °C at 1 minute intervals.
2.7. Isolation of mitochondria
Following treatments, approximately 400,000 cells total obtained
from 4 wells of a 24 well plate were harvested by trypsinization and
centrifuged at 700g for 10 minutes at 4 °C. The cell pellets were
washed once in PBS and then resuspended in 3 volumes of isolation
buffer (20 mMHepes, pH 7.4, 10 mM KCl, 1.5 mMMgCl2, 1 mM sodi-
um EDTA, 1 mM dithiothreitol, 10 mM phenylmethylsulfonyl ﬂuo-
ride, 10 μM leupeptin and 10 μM aprotinin) in 250 mM sucrose.
After chilling on ice for 3 minutes, the cells were disrupted by 40
strokes of a glass homogenizer. The homogenate was centrifuged
twice at 1500g at 4 °C to remove unbroken cells and nuclei. The
mitochondria-enriched fraction was then pelleted by centrifugation
at 12,000g for 30 minutes.
2.8. Measurement of glutamate dehydrogenase-1 activity
Glutamate dehydrogenase (GDH-1) activity in HeLa cells was mea-
sured using the GDH activity assay kit from BioVision (Mountain
View, CA). Brieﬂy, 50,000 cells/wellwere plated in 24well plates. Trans-
fectionwas carried out as described above. Forty eight hours after trans-
fection, cells from four wells were harvested by trypsinization and
washed twicewith ice cold PBS. Mitochondria were isolated and lysates
prepared. Optical density at 450 nm was measured with a Synergy HT
microplate reader (BioTek,Winooski, VT) at 37 °C at 3 minute intervals
for 1 hour. The results are expressed as the percentage increase or
decrease in activity compared to non-treated cells transfected with
non-targeting control siRNA.
2.9. Measurement of mitochondrial glutathione
Glutathione (GSH) was estimated using a monobromobimane
ﬂuorochrome based assay according to the manufactures instruction
(Millipore, Billerica, MA). Brieﬂy, 50,000 cells/well were plated in 24
well plate. Transfection was carried out as described above. Forty
eight hours after transfection, cells from four wells were harvested
by trypsinization and washed twice with ice cold PBS. All procedures
were done on ice and as rapidly as possible to prevent GSH oxidation.
Mitochondria were isolated and lysates prepared. The supernatant
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Fig. 1.Measurement and control of PTP induction in permeabilized cells. A and B. HeLa cells were loaded with 200 nM TMRM in DMEM for 30 minutes. The cells were then washed
twice with PBS and incubated further for 5 minutes in respiratory buffer containing 20 nM of TMRM. Digitonin at 2.5 μg/ml was then added to permeabilize the plasma membrane
and the cells were mounted on a heated stage kept at 37 °C. Where indicated, cells were pretreated with 10 μM of cyclosporin A or ruthenium red for 5 minutes. Phenylarsine oxide
(PAO) or Ca2+ was added at ﬁnal concentrations of 5 μM and 250 μM, respectively. TMRM ﬂuorescence was monitored over a 20 minute time course. 5 μM of CCCP was added at
the 18 minute time point. The result is the average of three independent experiments.
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at excitation of 308 nm and emission of 460 nm using Synergy HT
microplate reader. The results are presented as percentage of GSH
content compared to non-treated and non target transfected cells.
2.10. Measurement of mitochondrial Ca2+ retention capacity
The Ca2+ retention capacity was measured ﬂuorimetrically on a
microplate reader at 37 °C in the presence of the Ca2+ indicator Calcium
Green-5N (1 μM; excitation: 505 nm; emission: 535 nm; Molecular
Probes). Whole cells were placed in respiratory buffer containing
1 mM succinate and permeabilized with digitonin. Calcium was added
in pulses of 10 μM and uptake measured as a decrease of Calcium
Green-5N ﬂuorescence. Calcium was added in pulses until onset of the
PTP occurred as indicated by a rapid rise of calcium-green-5 N ﬂuores-
cence. To allow calculation of medium Ca2+ from the measured ﬂuores-
cence values, eachexperimentwas ended by the addition of 10 μMof the
uncoupler carbonylcyanide 3-chlorophenylhydrazone (CCCP) followed
by 400 μM EGTA, to be in excess of total Ca2+ added during the study
RE
to determine theminimum ﬂuorescence intensity (Fmin) value, followed
by 4 mMCaCl2 to determine themaximum ﬂuorescence intensity (Fmax)
value. The results are average of three independent experiments.
2.11. Statistical analysis
Results are expressed as means±s.d. of at least three independent
experiments. Statistical signiﬁcance was deﬁned at Pb0.05.
3. Results
3.1. Determination of mitochondrial permeability transition in perme-
abilized cells
As shown in Fig. 1A, trace #1, as measured by TMRM ﬂuorescence,
HeLa cells permeabilized with digitonin maintain a relatively stable
mitochondrial membrane potential. Signiﬁcantly, addition of the
mitochondrial un-coupler, CCCP, at 18 minutes caused a rapid decline
of TMRM ﬂuorescence, indicating depolarization of the mitochondria.
Sirt-3
GDH-1
CyP-D
Sirt-4
Sirt-4
siRNA
Sirt-3
siRNA
GDH-1
siRNA
CyP-D
siRNA
A
Ca2+ 250uM 1.
2.
3.
4.
B
C PAO 5uM
1.
2.
3.
4.
Fig. 2. Sirt-4 controls sensitivity to PTP induction by Ca2+ and PAO. A. HeLa cells were plated and then transfected with siRNAs targeting sirt-4, sirt-3, sirt-5, cyclophilin-D or a
non-targeting control. Following 48 hours, the cells were harvested. Mitochondrial extracts were prepared and separated on 12% SDS-PAGE gels followed by blotting to PVDF mem-
branes. The western blots were developed with antibodies against sirt-4, CyP-D, GDH-1, sirt-3 or sirt-5. The results are representative of three independent experiments. B and C.
HeLa cells were plated and then transfected with siRNAs targeting sirt-4, sirt-3, sirt-5 or cyclophilin-D. Following 48 hours, the cells were loaded with 200 nM TMRM in DMEM for
30 minutes. The cells were then washed twice with PBS and incubated further for 5 minutes in respiratory buffer containing 20 nM of TMRM. Digitonin at 2.5 μg/ml was then added
to permeabilize the plasma membrane and the cells were mounted on a heated stage kept at 37 °C. the cells were loaded with TMRM and mounted on a heated microscopy stage.
Following permeabilization with digitonin, Ca2+ or PAO were added at ﬁnal concentrations of 250 μM and 5 μM, respectively. Time-lapse microscopy was conducted over a 20 min-
ute time course with TMRM ﬂuorescence intensity assessed as described in Materials and methods. The result is the average of three independent experiments.
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of 250 μM also provoked mitochondrial depolarization (Fig. 1A, trace
#4). Signiﬁcantly, the depolarization brought about by Ca2+ was due
to sustained opening of the permeability transition pore (PTP).
Cyclophilin-D is a critical mediator of PTP sensitivity, with cyclosporin
A (CsA) inhibiting the peptidyl-prolyl cis-trans isomerase activity of
cyclophilin-D and lessening sensitivity to PTP induction. A ﬁve min-
ute pretreatment with 10 μM of CsA completely prevented the calci-
um induced mitochondrial depolarization, but had no effect on loss
of TMRM ﬂuorescence upon subsequent addition of CCCP (Fig. 1A,
trace #2). Signiﬁcantly, inhibition of the calcium uniporter with
R
ruthenium-red, which inhibits mitochondrial calcium uptake, also
prevented induction of the PTP brought about by calcium (Fig. 1A,
trace #3).
Phenylarsine oxide (PAO) induces PTP opening independently of
an increase of Ca2+ by an oxidative dependent cross-linking of PTP
components. As shown in Fig. 1B, trace #4, addition of 5 μM PAO in-
duced rapid mitochondrial depolarization, which was prevented by
pre-treatment with CsA (Fig. 1B, trace #2). As would be expected,
ruthenium-red had no effect on the ability of PAO to induce the PTP,
since in this instance, PTP induction is calcium independent (Fig. 1B,
trace #3). These results conﬁrm that the permeabilized cell system
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agents capable of inducing and inhibiting the PTP.
3.2. Suppression of sirtuin-4 prevents Ca2+ and PAO induction of the PTP
HeLa cells were transfectedwith siRNAs targeting sirtuin-4, sirtuin-3,
glutamate dehydrogenase I (GDH-1) or CyP-D (cyclophilin-D). As shown
in Fig. 2A, the siRNAs selectively suppressed the expression of their tar-
gets while having minimal off-target effects. The siRNA targeting sirt-4
suppressed its expression by 85%±6% by densitometry analysis. Particu-
larly important is that the siRNA targeting sirt-4 had no effect on the
expression of cyclophilin-D. Similarly, GDH-1 and CyP-D suppressed
the expression of their respective targets by 89%±7%and 79%±5%,
respectively. As shown in Fig. 2B and C (trace #1), depletion of
cyclophilin-D (CyP-D) prevented PTP induction by both Ca2+ and PAO,
respectively. Remarkably, as shown in Fig. 2B, trace #2, cells in which
sirt-4 was depleted exhibited robust resistance to PTP induction brought
about by the addition of Ca2+. Similarly, depletion of sirtuin-4 rendered
mitochondria resistant to PTP induction by PAO to the same degree as
CyP-D knock-down (Fig. 2C, trace #2). Importantly, suppression of
sirt-3 or sirt-5, both localized to the mitochondria, did not prevent PTP
induction by either Ca2+ or PAO (Fig. 2B and C, traces #3 and #4,
respectively).
Induction of the PTP is frequently accompanied by an increased
generation of reactive oxygen species (ROS) by mitochondria. The
ﬂuorescent probe, MitoSOX, localizes to the mitochondria and ex-
hibits increased ﬂuorescence upon stimulation of mitochondrial su-
peroxide anion production. As shown in Fig. 3A, addition of 1 mM
of H2O2 brought about a 57% increase of MitoSOX ﬂuorescence over
a twenty minute time course, indicating the ability of MitoSOX to de-
tect ROS in the permeabilized cell system. Importantly, induction of
the PTP by Ca2+ or PAO was accompanied by generation of ROS. Ex-
posure to 250 μM of Ca2+ or 5 μM of PAO induced a 43–46% stimula-
tion of ROS generation in cells transfected with non-targeting siRNA
(Fig. 3A and B, respectively). The generation of ROS by Ca2+ or PAO
was due to PTP induction, as both were prevented by either suppress-
ing cyclophilin-D expression or pretreatment with CsA (Fig. 3A and
B). Importantly, as with mitochondrial depolarization, depletion of
sirt-4 prevented ROS production induced by both Ca2+ and PAO to
the same degree as depletion of cyclophilin-D or pre-treatment with
CsA (Fig. 3A and B).
Mitochondria produce superoxide anion, which is converted to
H2O2 by mitochondrial superoxide anion dismutase. Utilizing the
Amplex-Red assay, we determined the rate of H2O2 production. As
shown in Fig. 3C, the addition of 250 μM of Ca2+ or 5 μM of PAO to
permeabilized Hela cells resulted in an over 5 fold increase in the
rate of H2O2 production. Importantly, suppression of CyP-D expres-
sion inhibited H2O2 production brought about by Ca2+ or PAO as
did depletion of sirt-4, suggesting that both prevent H2O2 production
by inhibiting onset of the PTP.
3.3. Modulation of the PTP by sirt-4 is dependent on glutamate
dehydrogenase-1
Sirt-4 ADP ribosylates and inactivates glutamate dehydrogenase-1
(GDH-1); therefore the protective effect of depleting sirt-4 against
PTP induction maybe due to activation of GDH-1. If this is the case,
then suppression of GDH-1 expression should restore PTP sensitivity
when sirt-4 levels are depleted. Therefore HeLa cells were concomi-
tantly transfected with siRNAs targeting sirt-4 and GDH-1. As show
in Fig. 4A and B, traces #2, depletion of GDH-1 reversed the protective
effect exerted by suppressing sirt-4 expression on PTP induction
brought about by either Ca2+ or PAO, respectively. Importantly, de-
pletion of GDH-1 did not reverse the inhibition of PTP induction
mediated by suppression of CyP-D, indicating that GDH-1 acts specif-
ically in a sirt-4 dependent pathway to modulate PTP sensitivity
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tion by down-regulation of sirt-4 was also dependent on GDH-1 ex-
pression. As shown in Fig. 4C and D, depletion of GDH-1 prevented
down-regulation of sirt-4 from inhibiting Ca2+ or PAO induced ROS
generation, with the addition of Ca2+ or PAO triggering a 45%–58%
increase in ROS production in cells where sirt-4 and GDH-1 were
concomitantly down-regulated, respectively. By contrast, depletion
of GDH-1 expression did not reverse the ability of CyP-D suppression
to prevent Ca2+ or PAO induced ROS production, with only a 10–12%
stimulation of ROS production when CyP-D and GDH-1 were concom-
itantly down-regulated, indicating that unlike sirt-4, CyP-D modula-
tion of PTP induced ROS production is not dependent on GDH-1
expression (Fig. 4C and D). Similarly, the ability of sirt-4 depletion
to prevent an increased rate of H2O2 production was dependent on
the expression of GDH-1. As shown in Fig. 4E, suppression of GDH-1
expression reversed the protective effect of sirt-4 depletion against
Ca2+ and PAO stimulation of H2O2 production. By contrast, the ability
of CyP-D depletion to prevent onset of H2O2 production by Ca2+ or
PAO was not dependent on GDH-1.
In addition to reversing the protective effect against PTP induction
exerted by sirt-4 depletion, suppression of GDH-1 potentiated PTP in-
duction triggered by sub-threshold doses of Ca2+ and PAO. As shown
in Fig. 5A, trace #1, in cells transfected with a non-targeting siRNA, a
50 μM dose of Ca2+ induced the PTP to a much lesser extent than a
250 μMdose, exhibiting a longer lag phase to PTP induction and incom-
plete depolarization over a twentyminute time course, indicating that a
large proportion of themitochondria were resistant to PTP induction by
this low dose of Ca2+. By contrast, when GDH-1 levels were depleted,
50 μM of Ca2+ induced rapid and complete PTP induction, comparable
in rapidity and extent to that induced by a 250 μMdose of Ca2+ in con-
trol cells (Fig. 5A, trace #2). Similarly, a sub-threshold dose of PAO
(2.5 μM) that induced incomplete depolarization in cells transfected
with non-target siRNA (Fig. 5B, trace #1), induced rapid and complete
loss of membrane potential in cells where GDH-1 levels are depleted
(Fig. 5B, trace #2).
Leucine is an allosteric stimulator of GDH-1 [16,17]. As show in
Fig. 5C, trace #2, in cells transfected with non-targeting siRNA, treat-
ment with 250 μM Ca2+ induced rapid mitochondrial depolarization.
By contrast, cells pretreated for 5 minutes with 1 mM of leucine were
refractory to PTP induction brought about by the addition of 250 μM
calcium (Fig. 5C, trace #1). Moreover, the ability of leucine to prevent
PTP induction was dependent on expression of GDH-1. As shown in
Fig. 5C, trace #3, depletion of GDH-1 neutralized the ability of leucine
to prevent PTP induction by calcium, indicating that prevention of the
PTP by leucine is dependent on GDH-1 expression. Similarly, exposure
of cells transfected with non-targeting siRNA to 5 μM of PAO brought
about rapid mitochondrial depolarization that was prevented by
pretreatment with 1 mM of leucine (Fig. 5D, traces #2 and #1, respec-
tively). However as with Ca2+, the ability of leucine to prevent induc-
tion of the PTP by PAO was dependent on GDH-1, with depletion of
GDH-1 reversing the protective effect of leucine (Fig. 5D, trace #3).
These data indicate that GDH-1 increases the threshold for PTP induc-
tion and that when the negative regulation exerted on GDH-1 by
sirt-4 is removed, PTP induction is blunted.
In order to verify the results obtained utilizing ﬂuorescence micros-
copy, a plate reader assaywas employed to determine the ability of dig-
itonin permeabilized cells to retain TMRM upon a challenge with Ca2+
or PAO. As shown in Fig. 5E, in agreementwith the results obtainedwith
ﬂuorescence microscopy, the addition of 250 μM of Ca2+ to digitonin
permeabilized cells transfected with non-targeting siRNA resulted in a
93% loss of TMRM ﬂuorescence. By contrast, cells pre-treated with CsA
or depleted of CyP-D were resistant to calcium induced loss of TMRM
ﬂuorescence, exhibiting only a 10%–15% loss of TMRM ﬂuorescence,
indicating that the mitochondrial depolarization is due to opening of
the PTP. Similarly, the addition of 5 μM of PAO brought about a 95%
loss of TMRM ﬂuorescence that was prevented by pre-treatment with
CT
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Fig. 3. Down-regulation of sirt-4 prevents PTP dependent ROS production. A and B. HeLa cells were plated and then transfected with siRNAs targeting sirt-4, cyclophilin-D or a
non-targeting control. Following 48 hours the HeLa cells were loaded with 200 nM MitoSOX in DMEM for 30 minutes. The cells were then washed twice with PBS and incubated
further for 5 minutes in respiratory buffer containing 20 nM of MitoSOX. Digitonin at 2.5 μg/ml was then added to permeabilize the plasma membrane and the cells were mounted
on a heated stage kept at 37 °C. Where indicated, cells were pretreated with 10 μM of cyclosporin A for 5 minutes. Ca2+ and PAO were added at ﬁnal concentrations of 250 μM and
5 μM, respectively. Time-lapse microscopy was conducted over a 20 minute time course with MitoSox ﬂuorescence intensity assessed as described in Materials and methods. The
results are the mean of three independent experiments±the standard deviation. C. HeLa cells were plated and then transfected with siRNAs targeting sirt-4 or CyP-D. Following
48 hours, the cells were placed in respiratory buffer and permeabilized with digitonin (2.5 μg/ml). Amplex-red reagent was added at 5 μM along with 10 U/ml of horseradish per-
oxidase. Following addition of Ca2+ or PAO, ﬂuorescence intensity was measured using a Synergy HT microplate reader with an excitation of 570 nm and emission at 585 nm at
37 °C at 1 minute intervals. The results are the mean of three independent experiments±the standard deviation.
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prevented Ca2+ and PAO induction of the PTP (Fig. 5E). In contrast
to CsA or suppression of CyP-D expression, depletion of sirt-4 re-
quired the expression of GDH-1 to prevent PTP induction by Ca2+
or PAO (Fig. 5F). Suppression of GDH-1 expression reversed the pro-
tective effect exerted by depletion of sirt-4 against Ca2+ and PAO in-
duced loss of TMRM ﬂuorescence (green bar). Importantly,
activation of GDH-1 by leucine also prevented induction of the PTP
by Ca2+ and PAO, which was reversed by depletion of GDH-1
(Fig. 5F, yellow and blue bars, respectively). However, depletion of
GDH-1 did not reverse the protective effect exerted by pre-
treatment with CsA or suppression of CyP-D expression on Ca2+ or
PAO induction of the PTP, indicating that sirt-4 prevents the PTP
R via a GDH-1 dependent mechanism distinct from that mediated byinhibition of cyclophilin-D (Fig. 5F).
3.4. Sirt-4 increases mitochondrial calcium retention capacity
Desensitization to PTP opening increases the ability of mitochon-
dria to take up calcium, thereby lessening cellular injury when
calcium homeostasis is perturbed. Control, non-treated HeLa cells
displayed a calcium retention capacity of 250 nmole of Ca2+/mg mi-
tochondrial protein. As shown in Fig. 6, as expected, treatment with
CsA or suppression of CyP-D expression increased the ability of mito-
chondria to retain calcium by 87% and 93%, respectively. Importantly,
depletion of sirt-4 enhanced calcium retention to the same degree,
A B
C D
Ca2+
250uM
PAO
5uM1.
2.
1.
2
E
Fig. 4. Glutamate dehydrogenase-1 expression is necessary for sirt-4 depletion to protect against the PTP. A and B. HeLa cells were plated and then transfected with an siRNA
targeting GDH-1 simultaneously with siRNAs targeting sirt-4 or cyclophilin-D. Following 48 hours, HeLa cells were loaded with 200 nM TMRM in DMEM for 30 minutes. The
cells were then washed twice with PBS and incubated further for 5 minutes in respiratory buffer containing 20 nM of TMRM. Digitonin at 2.5 μg/ml was then added to permeabilize
the plasma membrane and the cells were mounted on a heated stage kept at 37 °C. Following permeabilization with digitonin, Ca2+ and PAO were added at ﬁnal concentrations of
250 μM and 5 μM, respectively. Time-lapse microscopy was conducted over a 20 minute time course with TMRM ﬂuorescence intensity assessed as described in Materials and
methods. The result is the average of three independent experiments. C and D. HeLa cells were plated and then transfected with an siRNA targeting GDH-1 simultaneously with
siRNAs targeting sirt-4 or cyclophilin-D. Following 48 hours, the cells were loaded with 200 nM of MitoSOX in DMEM for 30 minutes. The cells were then washed twice with
PBS and incubated further for 5 minutes in respiratory buffer containing 20 nM of MitoSOX. Digitonin at 2.5 μg/ml was then added to permeabilize the plasma membrane and
the cells were mounted on a heated stage kept at 37 °C. Following permeabilization with digitonin, Ca2+ and PAO were added at ﬁnal concentrations of 250 μM and 5 μM, respec-
tively. Time-lapse microscopy was conducted over a 20 minute time course with MitoSOX ﬂuorescence intensity assessed as described in Materials and methods. The results are the
mean of three independent experiments±the standard deviation. E. HeLa cells were plated and then transfected with siRNAs targeting sirt-4, CyP-D individually or in tandem with
siRNA targeting GDH-1. Following 48 hours, the cells were placed in respiratory buffer and permeabilized with digitonin (2.5 μg/ml). Amplex-red reagent was added at 5 μM along
with 10 U/ml of horseradish peroxidase. Following addition of Ca2+ or PAO, ﬂuorescence intensity was measured using Synergy HT microplate reader with an excitation of 570 nm
and emission at 585 nm at 37 °C at 1 minute intervals. The results are the mean of three independent experiments±the standard deviation.
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Dincreasing capacity by 94%. Intriguingly, suppression of GDH-1
decreased calcium retention capacity to below control levels, in
agreement with the notion that loss of GDH-1 expression potentiates
induction of the PTP. Moreover, the ability of sirt-4 to increase calci-
um retention capacity is dependent on GDH-1 expression. Suppres-
sion of GDH-1 reversed the ability of sirt-4 depletion to enhancecalcium retention capacity, depressing calcium retention capacity to
levels below that of control. Similarly, stimulation of GDH-1 activity
with leucine increased calcium retention capacity that in turn was re-
versed by depletion of GDH-1. By contrast, the ability of CsA to in-
crease calcium retention capacity was not dependent on GDH-1
expression (Fig. 6).
A Ca2+
50uM PAO 1uM
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Fig. 5. Glutamate dehydrogenase regulates PTP sensitivity. A and B. HeLa cells were plated and then transfected with siRNAs targeting GDH-1 or a non-targeting control. Following
48 hours, HeLa cells were loaded with 200 nM TMRM in DMEM for 30 minutes. The cells were then washed twice with PBS and incubated further for 5 minutes in respiratory buffer
containing 20 nM of TMRM. Digitonin at 2.5 μg/ml was then added to permeabilize the plasma membrane and the cells were mounted on a heated stage kept at 37 °C. Following
permeabilization with digitonin, Ca2+ or PAO were added at ﬁnal concentrations of 50 μM and 2.5 μM, respectively. Time-lapse microscopy was conducted over a 20 minute time
course with TMRM ﬂuorescence intensity assessed as described in Materials and methods. The result is the average of three independent experiments. C and D. HeLa cells were
plated and then transfected with siRNAs targeting GDH-1 or a non-targeting control. Following 48 hours, HeLa cells were loaded with 200 nM TMRM in DMEM for 30 minutes.
The cells were then washed twice with PBS and incubated further for 5 minutes in respiratory buffer containing 20 nM of TMRM. Digitonin at 2.5 μg/ml was then added to
permeabilize the plasma membrane and the cells were mounted on a heated stage kept at 37 °C. Following permeabilization with digitonin, leucine at a ﬁnal concentration of
1 mMwas added. Following 5 minutes of pre-incubation with 1 mM leucine, Ca2+ or PAO were added at ﬁnal concentrations of 250 μM and 5 μM, respectively. Time-lapse micros-
copy was conducted over a 20 minute time course with TMRM ﬂuorescence intensity assessed as described in Materials and methods. The results are the mean of three indepen-
dent experiments±the standard deviation. E and F. HeLa cells were plated at 50,000 cells/well in 24 well plates and transfected with the indicated siRNA. After 48 hours, the cells
were loaded with 200 nM TMRM in DMEM for 30 minutes. The cells were incubated further for 5 minutes in respiratory buffer containing 2.5 μg/ml digitonin and 20 nM of TMRM.
Fluorescence intensity was measured using a Synergy HT microplate reader with an excitation of 550 nm and emission at 573 nm at 37 °C at 1 minute intervals. After 4 minutes,
either phenylarsine oxide or Ca2+ was added at the indicated concentrations, with ﬂuorescence measured over 20 minutes. The results are presented as % of TMRM retained in
non-treated cells transfected with non target siRNA at the 20 minute time point. The results are the mean of three independent experiments±the standard deviation.
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A stimulation of GDH-1 activity can increase synthesis of NADPH,
which in turn can be utilized in the production of reduced glutathione
(GSH). Glutathione is an antioxidant, suggesting the possibility that de-
pletion of sirt-4 protects against the PTP by promoting the production ofGSH. Control cells or cells transfected with non-targeting siRNA
displayed mitochondrial GDH-1 activity of 1.86 μmol/min/mg protein).
As shown in Fig. 7A, depletion of sirt-4 stimulatedmitochondrial GDH-1
activity to 74% above that seen in untreated control cells. Similarly, as
expected the addition of leucine also stimulated GDH-1 activity to 79%
above control levels. Importantly, stimulation of GDH-1 activity with
Fig. 6. Depletion of Sirt-4 enhances mitochondrial calcium retention capacity. HeLa cells
were plated at 50,000 cells/well in 24 well plates and transfected with the indicated
siRNA. After 48 hours, the cells were incubated for 5 minutes in respiratory buffer
containing 2.5 μg/ml digitonin and 1 μM of the Ca2+ indicator, Calcium Green-5N
(excitation 505 nm; emission: 535 nm; Molecular Probes). Calcium was added in pulses
of 10 μM and uptake measured as a decrease of Calcium Green-5N ﬂuorescence. The
results are the mean of three independent experiments±the standard deviation.
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leucine or by suppression of sirt-4 expression, were both prevented by
transfection with siRNA targeting GDH-1. However, despite activating
GDH-1, neither depletion of sirt-4 nor the addition of leucine caused
an elevation of mitochondrial GSH levels. The concentration of glutathi-
one in mitochondria isolated from control non-treated cells was
6 nmole/mg mitochondrial protein. The concentration of GSSG was
0.3 nmole/mg mitochondrial protein. As shown in Fig. 7B, depletion of
sirt-4 or stimulation with leucine did not bring about any appreciable
change in the mitochondrial reduced or oxidized glutathione concen-
tration. Surprisingly, depletion of GDH-1 did not provoke a decline of
mitochondrial GSH. However, the addition of Ca2+ did promote a de-
pletion of mitochondrial GSH and increase of GSSG. However, this is
most likely due to opening of the PTP and subsequent loss of GSH, as
the Ca2+ induced depletion of GSH is prevented by suppression of
CyP-D expression or treatment with CsA. Similarly, suppression of
sirt-4 expression also prevented the Ca2+ induced loss ofmitochondrial
GSHand increase of GSSG, as did stimulation ofGDH-1 activitywith leu-
cine. Importantly stimulation of GDH-1 activity by depletion of sirt-4 or
addition of leucine did not increase or decrease the GSH/GSSG ratio
(Fig. 7C). Together, these data suggest that stimulation of GDH-1 does
not cause an absolute increase ofmitochondrial GSH levels and the abil-
ity of GDH-1 stimulation to prevent onset of the PTP cannot be
accounted for solely by modulation of mitochondrial GSH levels.
3.6. Sirt-4 mediates PTP dependent cytotoxicity
We and others have previously demonstrated that TNF induced
necroptosis is dependent on PTP induction [18–20]. As shown in
Fig. 8A, in L929 ﬁbrosarcoma cells, TNF in the presence of the
pan-caspase inhibitor, ZVAD-FMK, induces a massive loss of cell via-
bility, with only 8% of cells transfected with non-target siRNA
remaining viable after 24 hours of exposure (black bar). Suppression
of CyP-D expression blunted TNF+ZVAD induced cytotoxicity, with
68% of the cells still viable after 24 hours of exposure, demonstrating
that in this instance, TNF induced cytotoxicity is PTP dependent
(Fig. 8A, red bar). Markedly, suppression of sirt-4 expression also
prevented TNF+ZVAD induced cytotoxicity, with 70% of the cells
still viable after 24 hours of exposure (Fig. 8A, green bar). By contrast,
suppression of sirt-3 or sirt-5 exhibited no ability to prevent
TNF+ZVAD induced cell killing (results not shown). Importantly,
the ability of sirt-4 down-regulation to inhibit TNF+ZVAD induced
cytotoxicity was dependent on GDH-1 expression. As show in
Fig. 8A, depletion of GDH-1 reversed the protective effect afforded
by sirt-4 down-regulation against TNF+ZVAD induced cytotoxicity,
RE
TRwith less than 10% of the cells remaining viable after 24 hours of ex-
posure (yellow bar). Importantly, as with PTP induction in mitochon-
dria, depletion of GDH-1 had no effect on the ability of CyP-D
suppression to protect against TNF+ZVAD induced cytotoxicity,
with 67% of the cells still viable after 24 hours of exposure (Fig. 8A,
blue bar).
Doxorubicin induced cytotoxicity is also dependent on PTP induc-
tion [21–23]. As shown in Fig. 8B, doxorubicin at a dose of 50 μM left
only 14% of HeLa cells transfected with non-targeting siRNA viable
following 18 hours of treatment (black bar). By contrast, suppression
of CyP-D or sirt-4 largely prevented doxorubicin induced cytotoxicity,
with greater than 70% of the cells still viable following 18 hours of
treatment. (Fig. 8B, red and green bars, respectively). Moreover, as
with TNF+ZVAD, the protection afforded against doxorubicin in-
duced cytotoxicity brought about by suppressing sirt-4 expression
was dependent on GDH-1. As shown in Fig. 6B, depletion of GDH-1 re-
versed the protective effect of sirt-4 suppression, with only 14% of the
cells remaining viable after 18 hours of doxorubicin treatment
(yellow bar). By contrast, depletion of GDH-1 did not reverse the pro-
tective effect exerted by knock-down of CyP-D, with cell viability
maintained at 75% following 18 hours of treatment with doxorubicin
(Fig. 8B, blue bar), indicating that the protective effect exerted by
down-regulating sirt-4 is dependent on GDH-1, whereas the protec-
tion afford by CyP-D suppression is not.
4. Discussion
The present study demonstrates that sirt-4 modulates sensitivity
to PTP induction and that this may be mediated partly through regu-
lation of glutamate dehydrogenase-1. Depletion of sirt-4 prevented
PTP induction brought about by Ca2+ or PAO. Additionally, sirt-4 ex-
pression mediated sensitivity to PTP dependent cell death, with sup-
pression of sirt-4 levels preventing TNF+ZVAD and doxorubicin
induced cytotoxicity. Importantly, inhibition of PTP sensitivity by
down-regulation of sirt-4 is dependent on GDH-1 expression. Deple-
tion of GDH-1 negated the protective effect exerted by suppressing
sirt-4 levels against PTP induction brought about by Ca2+ and PAO,
and also prevented sirt-4 suppression from inhibiting TNF+ZVAD
or doxorubicin induced cytotoxicity. By contrast, suppression of PTP
induction or inhibition of PTP dependent cytotoxicity by down-
regulating CyP-D was insensitive to GDH-1 levels. Moreover,
pre-treatment with the GDH-1 allosteric activator, leucine, prevented
PTP induction, with depletion of GDH-1 reversing the protective ef-
fect of leucine. These data suggest that by negatively regulating
GDH-1, sirt-4 increases sensitivity to PTP induction and that when
sirt-4 levels are suppressed, activation of GDH-1 promotes resistance
to PTP induction and subsequent cytotoxicity.
The regulation of GDH-1 activity by ADP-ribosylation was noted
before the identiﬁcation of sirt-4 as the enzyme responsible for the
modiﬁcation [24,25]. GDH-1 is active as a homohexamer, but the stoi-
chiometry between incorporated ADP-ribose and GDH-1 subunits in-
dicates that ADP-ribosylation of one subunit of the hexameric
complex maybe all that is needed for its inactivation [26]. The cyste-
ine residue at position 119 is the site ADP-ribosylated by sirt-4, but
curiously is thought not to be directly involved in GDH-1 catalysis,
as cysteine residue 323 has been shown to be. In addition to
ADP-ribosylation, GDH-1 is controlled by a number of allosteric effec-
tors including ADP, ATP, GDP, GTP and leucine [16,17].
Sirt-4 is localized to the mitochondrial matrix but possesses no
deacetylase activity. Rather, sirt-4 ADP-ribosylates GDH-1, thereby
inhibiting its activity and provoking a number of metabolic alter-
ations [14]. In pancreatic β cells, suppression of sirt-4 resulted in ac-
tivation of GDH-1 that in turn provoked an increase in insulin
secretion in response to glucose [15]. The ability of GDH-1 to promote
insulin secretion was also identiﬁed in dominant mutations of GDH-1
that cause reduced GTP inhibition of the enzyme, resulting in a
CT
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Fig. 7. GDH-1 activity and mitochondrial GSH. A. HeLa cells were plated at 50,000 cells/well in 24 well plates and transfected with the indicated siRNA. Forty eight hours after trans-
fection, cells from 4 wells were harvested by trypsinization and washed twice with ice cold PBS. Mitochondria were isolated and lysates prepared. Optical density at 450 nm was
measured with Synergy HT microplate reader (BioTek, Winooski, VT) at 37 °C at 3 minute intervals for 1 hour. The results are expressed in percentage increase or decrease in ac-
tivity compared to non-treated cells transfected with non-targeting control siRNA. The results are the mean of three independent experiments±the standard deviation. B. HeLa
cells were plated at 50,000 cells/well in 24 well plates and transfected with the indicated siRNA. Forty eight hours after transfection, cells from 4 wells were harvested by
trypsinization and washed twice with ice cold PBS. Mitochondria were isolated and lysates prepared. The supernatant was used to determine the GSH content. Fluorescence
was measured at excitation of 308 nm and emission of 460 nm using a Synergy HT microplate reader. The results are presented as percentage of GSH content compared to
non-treated and non-target transfected cells. The results are the mean of three independent experiments±the standard deviation. C. The GSH/GSSG ratio was calculated from
the measured concentrations of GSH and GSSG.
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also been shown to interact with insulin degrading enzyme (IDE)
and adenine nucleotide translocase 2 (ANT-2). ANT-2 mediates the
uptake of ATP from the cytosol into the mitochondria and exhibits
increased expression in highly glycolytic cancer cells [28,29]. Expres-
sion of ANT-2 is associated with inhibition of apoptosis, although the
exact mechanism by which it exerts this effect is unclear. However
down-regulating ANT-2 or IDE had no effect on the ability of sirt-4
to modulate sensitivity to PTP induction (results not shown). Intrigu-
ingly, mutations of the pancreatic duodenal homeobox gene-1
(Pdx-1) cause heritable diabetes in humans and mice, brought
about by increased pancreatic beta cell death mediated by onset of
the PTP, suggesting that in pancreatic beta cells, sirt-4 may contribute
to regulation of the PTP [30,31].
R Themechanism bywhich suppression of sirt-4 inhibits PTP inductionis unclear. The dependence on GDH-1 expressionmay indicate that it in-volves metabolic alterations in mitochondrial metabolism. In an
anapleurotic reaction, increased GDH-1 activity funnels glutamate into
the tricarboxylic acid cycle viaα-ketoglutarate dehydrogenase, resulting
in an elevation of NADPH, NADH and ATP production; all of which in-
crease the threshold for PTP induction. [26] Alternatively, once activated,
GDH-1 in its hexameric conﬁguration may interact with a component of
the PTP to inhibit assembly of the pore complex. Interestingly, before the
concept of a permeability transition pore emerged, it was shown that
ADP-ribosylation controlled sensitivity to the mitochondrial permeabili-
ty transition [32–35]. Mono-ADP-ribosylation of mitochondrial proteins
is stimulated by pro-oxidants and is associatedwith loss of mitochondri-
al membrane integrity. It is possible that the ADP-ribosyltransferase
Fig. 8. Down-regulation of sirt-4 prevents TNF and doxorubicin cytotoxicity. A and B. HeLa cells were transfected with 50 nM of a non-targeting control siRNA or siRNAs targeting
sirt-4 or CyP-D, separately or in tandem with siRNA targeting GDH-1 or siGDH-1 alone. Following 48 hours incubation, the cells were incubated with 20 ng/ml of TNFα in the pres-
ence of 20 μMof ZVAD, or treated with 10 μM of doxorubicin. After 24 hours, the cells were harvested and cell viability assessed utilizing propidium iodide as described in Materials
and methods. Values are the means of three independent experiments with the error bars indicating standard deviations.
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activity responsible for this phenomenon is partlymediated by sirt-4. In-
deed, it maybe that sirt-4 ADP-ribosylates and modulates multiple tar-
gets that impact sensitivity to PTP induction.
In summary, the present study provides evidence indicating that
sirt-4 modulates sensitivity to mitochondrial PTP induction and PTP
dependent cytotoxicity that is in part dependent on GDH-1 (Fig. 9).AAcknowledgementsThis work was supported in part from grants from the NationalCancer Institute and the National Institute of Alcohol Abuse andAlcoholism.
GDH-1
Sirt-4
PTP
Fig. 9. Control of mitochondrial permeability transition pore sensitivity by Sirt-4. Pro-
posed pathway by which modulation of sirt-4 activity can stimulate GDH-1, which in
turn inhibits PTP opening and loss of cell viability.
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